Michael P. Phalen, EVP & President, Med Surg at BOSTON SCIENTIFIC CORP (BSX), sold 27,589 shares at $14.31 ($395K) on 2015-01-08, disclosed to the SEC on 2015-01-09.
Scheduled sale ($395k) by EVP & President, Med Surg under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BSX | SELL | 2017-10-30 | $441K | — | Filing → |
| BSX | SELL | 2017-10-02 | $445K | — | Filing → |
| BSX | SELL | 2017-08-30 | $416K | — | Filing → |